目前,全球的丙型肝炎病毒(HCV)感染者约有17000万例,其中大多数是慢性感染者,急性HCV感染往往是轻型或亚临床型,大约50％～70％的感染发展为慢性转氨酶升高。有些人有一系列的症状和体征,可从轻度的肝功能损害到肝硬化。干扰素治疗是唯一被证明有效的治疗方法,但其长期有效率也仅20％。为了提高药物治疗丙型肝炎的效果,各国学者都在探索新的治疗方案,最近报道干扰素与 Currently, there are about 170 million HCV infections in the world, the majority of whom are chronically infected. Acute HCV infection is often mild or subclinical and about 50% to 70% of infections develop chronic aminotransferases Rise. Some people have a range of symptoms and signs, ranging from mild liver damage to cirrhosis. Interferon therapy is the only proven effective treatment, but its long-term efficiency is only 20%. In order to improve the efficacy of drug treatment of hepatitis C, scholars from all over the world are exploring new treatment options. Recent reports on interferon and